BIOVERATIV THERAPEUTICS

ALTUVIIIO

Manufacturer:

BIOVERATIV THERAPEUTICS

Altuviiio HCPCS:

J7214

HCPCS Code Descriptor:

Injection, factor viii/von willebrand factor complex, recombinant (altuviiio), per factor viii i.u.

Category:

J Code

Altuviiio NDCs:

71104-0984-01, 71104-0983-01, 71104-0979-01, 71104-0982-01, 71104-0978-01, 71104-0981-01

Primary Type:

Hematology

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Altuviiio:

ALTUVIIIO is a Hematology drug manufactured by Bioverativ Therapeutics and administered via the intravenous route of administration. The J Code: J7214 is aligned to the drug ALTUVIIIO.

ACCESS PRICING AND MORE BY REGISTERING

J7214 Added Date:

October 1, 2023

J7214 Effective Date:

October 1, 2023

J7214 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Altuviiio billing and coding information.
Altuviiio patient assistance information can be found through Sanofi at the URL: https://www.alprolix.com/resources/financial-assistance.aspx
ALTUVIIIO prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for ALTUVIIIO. Please check back in a few weeks.